
Investigation launched into Chemours over alleged securities fraud after earnings miss and stock drop
Pomerantz LLP is investigating The Chemours Company for possible securities fraud following the company's reduced 2026 adjusted EBITDA guidance and admission of inventory issues. Chemours' stock dropped nearly 19% after the announcement. The investig...
